Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr 1;72(7):1795-803.
doi: 10.1158/0008-5472.CAN-11-3364. Epub 2012 Feb 13.

19p13.1 is a triple-negative-specific breast cancer susceptibility locus

Kristen N Stevens  1 Zachary FredericksenCeline M VachonXianshu WangSara MargolinAnnika LindblomHeli NevanlinnaDario GrecoKristiina AittomäkiCarl BlomqvistJenny Chang-ClaudeAlina VrielingDieter Flesch-JanysHans-Peter SinnShan Wang-GohrkeStefan NickelsHiltrud BrauchGENICA NetworkYon-Dschun KoHans-Peter FischerRita K SchmutzlerAlfons MeindlClaus R BartramSarah SchottChristoph EngelAndrew K GodwinJoellen WeaverHarsh B PathakPriyanka SharmaHermann BrennerHeiko MüllerVolker ArndtChrista StegmaierPenelope MironDrakoulis YannoukakosAlexandra StavropoulouGeorge FountzilasHelen J GogasRuth SwannMiriam DwekAnnie PerkinsRoger L MilneJavier BenítezMaría Pilar ZamoraJosé Ignacio Arias PérezStig E BojesenSune F NielsenBørge G NordestgaardHenrik FlygerPascal GuénelThérèse TruongFlorence MenegauxEmilie Cordina-DuvergerBarbara BurwinkelFrederick MarméAndreas SchneeweissChristof SohnElinor SawyerIan TomlinsonMichael J KerinJulian PetoNichola JohnsonOlivia FletcherIsabel Dos Santos SilvaPeter A FaschingMatthias W BeckmannArndt HartmannArif B EkiciArtitaya LophatananonKenneth MuirPuttisak PuttawibulSurapon WiangnonMarjanka K SchmidtAnnegien BroeksLinde M BraafEfraim H RosenbergJohn L HopperCarmel ApicellaDaniel J ParkMelissa C SoutheyAnthony J SwerdlowAlan AshworthNicholas OrrMinouk J SchoemakerHoda Anton-CulverArgyrios ZiogasLeslie BernsteinChristina Clarke DurChen-Yang ShenJyh-Cherng YuHuan-Ming HsuChia-Ni HsiungUte HamannThomas DünnebierThomas RüdigerHans Ulrich UlmerPaul P PharoahAlison M DunningManjeet K HumphreysQin WangAngela CoxSimon S CrossMalcom W ReedPer HallKamila CzeneChristine B AmbrosoneFoluso AdemuyiwaHelena HwangDiana M EcclesMontserrat Garcia-ClosasJonine D FigueroaMark E ShermanJolanta LissowskaPeter DevileeCaroline SeynaeveRob A E M TollenaarMaartje J HooningIrene L AndrulisJulia A KnightGord GlendonAnna Marie MulliganRobert WinqvistKatri PylkäsArja Jukkola-VuorinenMervi GripEsther M JohnAlexander MironGrethe Grenaker AlnæsVessela KristensenAnne-Lise Børresen-DaleGraham G GilesLaura BagliettoCatriona A McLeanGianluca SeveriMatthew L KoselV S PankratzSusan SlagerJanet E OlsonPaolo RadicePaolo PeterlongoSiranoush ManoukianMonica BarileDiether LambrechtsSigrid HatseAnne-Sophie DieudonneMarie-Rose ChristiaensGeorgia Chenevix-TrenchkConFab InvestigatorsAOCS GroupJonathan BeesleyXiaoqing ChenArto MannermaaVeli-Matti KosmaJaana M HartikainenYlermi SoiniDouglas F EastonFergus J Couch
Affiliations

19p13.1 is a triple-negative-specific breast cancer susceptibility locus

Kristen N Stevens et al. Cancer Res. .

Abstract

The 19p13.1 breast cancer susceptibility locus is a modifier of breast cancer risk in BRCA1 mutation carriers and is also associated with the risk of ovarian cancer. Here, we investigated 19p13.1 variation and risk of breast cancer subtypes, defined by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status, using 48,869 breast cancer cases and 49,787 controls from the Breast Cancer Association Consortium (BCAC). Variants from 19p13.1 were not associated with breast cancer overall or with ER-positive breast cancer but were significantly associated with ER-negative breast cancer risk [rs8170 OR, 1.10; 95% confidence interval (CI), 1.05-1.15; P = 3.49 × 10(-5)] and triple-negative (ER-, PR-, and HER2-negative) breast cancer (rs8170: OR, 1.22; 95% CI, 1.13-1.31; P = 2.22 × 10(-7)). However, rs8170 was no longer associated with ER-negative breast cancer risk when triple-negative cases were excluded (OR, 0.98; 95% CI, 0.89-1.07; P = 0.62). In addition, a combined analysis of triple-negative cases from BCAC and the Triple Negative Breast Cancer Consortium (TNBCC; N = 3,566) identified a genome-wide significant association between rs8170 and triple-negative breast cancer risk (OR, 1.25; 95% CI, 1.18-1.33; P = 3.31 × 10(-13)]. Thus, 19p13.1 is the first triple-negative-specific breast cancer risk locus and the first locus specific to a histologic subtype defined by ER, PR, and HER2 to be identified. These findings provide convincing evidence that genetic susceptibility to breast cancer varies by tumor subtype and that triple-negative tumors and other subtypes likely arise through distinct etiologic pathways.

PubMed Disclaimer

Figures

Figure 1
Figure 1. 19p13.1 (rs8170) association with risk of non-TN, ER-negative and TN breast cancer
Forest plots for rs8170 and risk of (a) non-TN, ER-negative breast cancer and (b) TN breast cancer are shown by country. Country-specific odds ratios (95% CIs) are denoted by black boxes (black lines). Overall OR estimates are represented by black diamonds, where diamond width corresponds to 95% CI bounds. Box and diamond heights are inversely proportional to precision of the OR estimate. P-values for heterogeneity (pHet) of odds ratios by country are shown.

References

    1. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007;39:865–9. - PubMed
    1. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008;40:703–6. - PubMed
    1. Garcia-Closas M, Chanock S. Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res. 2008;14:8000–9. - PMC - PubMed
    1. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008;4:e1000054. - PMC - PubMed
    1. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) Nat Genet. 2009;41:579–84. - PMC - PubMed

Publication types

Grants and funding